Study shows that Libtayo plus chemotherapy has lower cost and a larger effect on improving quality-adjusted life years than ...

Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase ...

A ~$4.5B share repurchase program adds further value. LIBTAYO demonstrated massive growth, accelerating to 50% in Q4 2024 versus Q4 2023. Approval in CSCC means that this growth catalyst is ...

THIO (6-thio-2′-deoxyguanosine), an investigational telomere-targeting agent sequenced in combination with Regeneron’s Libtayo (cemiplimab), a programmed cell death protein 1 (PD-1 ...

In the fourth quarter of 2024, Libtayo grew sales 50% to $367 million, propelling the PD-1 treatment past the blockbuster threshold for the first time. During the full year, the drug's sales reach ...

cemiplimab (Libtayo ®) in patients with advanced non-small cell lung cancer (NSCLC) who failed two or more standard-of-care therapy regimens. As of January 15, 2025, third line (3L) data showed ...

The pivotal phase II THIO-101 study of Thio, a telomere-targeting agent sequenced with Regeneron Inc.’s immune checkpoint inhibitor Libtayo (cemiplimab), as a third-line treatment for advanced ...

Commissions do not affect our editors' opinions or evaluations. Small business insurance costs an average of $249 per month ($2,988 per year) for a business owners policy, commercial auto ...

A basket of healthy food costs more than double that of less healthy options, according to new analysis. The Food Foundation found that 1,000 calories of healthy food such as fruit and veg costs ...

Netflix Inc. is raising prices again — though for some viewers, it’s actually been some time since the last hike. The company announced alongside its earnings Tuesday afternoon that it will be ...